MoonLake Immunotherapeutics (US: MLTX) — Healthcare · Share Price, Chart & Market Data
About: MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases in dermatology and rheumatology, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.
Sector: Healthcare
Industry: Biotechnology
Latest price: $17.18 (+1.48%)
MLTXMoonLake Immunotherapeutics
Loading watchlist status…
Trade MLTX now
MoonLake Immunotherapeutics share price
MLTX price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 11:15 am GMT+0
MLTX price performance
-2.149%
5D
-2.714%
1M
41.004%
YTD
-56.96%
1Y
MLTX price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 11:15 am GMT+0
MLTX details
MLTX Market Signals